Related Experiment Videos
[Extravasation of paclitaxel (Taxol)]
E Raymond1, S Cartier, C Canuel
1Service de Médecine Interne-Oncologie, Hôpital Saint-Antoine, Paris, France.
La Revue De Medecine Interne
|January 1, 1995
Summary
Paclitaxel, an antimitotic drug, can cause local skin necrosis if accidentally injected under the skin. Fortunately, this condition improved with localized treatment only.
Area of Science:
- Oncology
- Dermatology
- Pharmacology
Background:
- Paclitaxel is a vital antimitotic chemotherapy agent derived from the yew tree.
- It is widely used in treating ovarian and breast cancers.
- The local toxicity profile of paclitaxel, particularly following extravasation, remains incompletely understood.
Observation:
- This report details an early observation of accidental subcutaneous extravasation of paclitaxel.
- The patient developed localized epidermal necrosis at the site of extravasation.
Findings:
- The observed epidermal necrosis showed a positive response to localized treatment.
- The clinical course was favorable, indicating potential for conservative management.
Implications:
- This case highlights the importance of recognizing and managing paclitaxel extravasation.
- It suggests that localized treatment may be effective for managing subcutaneous paclitaxel extravasation.
- Further research into the local toxicity and management strategies for paclitaxel extravasation is warranted.